Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
A tacrolimus dosing strategy that considers the variability in hemoglobin levels applies to all patients undergoing HSCT.
Authors
- T Hotta (ORCID: https://orcid.org/0000-0002-7935-7285)
- Tatsuya Hirano (ORCID: https://orcid.org/0000-0002-4219-6473)
- Takayuki Ishikawa (ORCID: https://orcid.org/0000-0002-2098-9616)
- Haruno Oku
- Nobuyuki Muroi
- Hiroaki Ikesue (ORCID: https://orcid.org/0000-0002-8499-131X)
- Tohru Hashida (ORCID: https://orcid.org/0000-0002-5702-5124)
- Yoshimitsu Shimomura (ORCID: https://orcid.org/0000-0003-1018-9508)
- Hirohito Muroi
- Kei Irie (ORCID: https://orcid.org/0000-0002-0820-1208)
- Keizo Fukushima (ORCID: https://orcid.org/0000-0001-5753-6891)
- Saki Yoshida (ORCID: https://orcid.org/0009-0004-9160-6776)
- Nobuyuki Sugioka
Institutions
- Kobe Gakuin University (JP)
- Kobe City Medical Center General Hospital (JP)
Publication Details
- Journal
- Current Therapeutic Research
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.curtheres.2024.100775
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Japan Society for the Promotion of Science